NexImmune, Inc(NASDAQ:NEXI) 
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nan...
Website: http://www.neximmune.com
Founded: 2011
CEO: Scott Carmer
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2024-07-22
P
O 1.88
H 1.88
L 1.48
C 1.70
V 41,657
10EMA 1.70
20EMA 1.70
60EMA 1.70
120EMA 1.70
250EMA 1.70